Planning Strategies Inc.’s BioMarin Pharmaceuticals BMRN Stock Holding History

Planning Strategies Inc.’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$401	Buy	+7	New	+$383	﹤0.01%	896

Other funds holding BMRN

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

EIP

Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Covea Finance Paris, France $3.17B AUM 35.01% 1-Year Est. Return

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

Planning Strategies Inc.'s BMRN Position: Q2 2026 in Review

Planning Strategies Inc. opened a new position in BioMarin Pharmaceuticals (BMRN) in Q2 2026: 7 shares worth $401. The stake represents ﹤0.01% of the portfolio and ranks #896 among its holdings.

142 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Planning Strategies Inc. held 7 shares of BioMarin Pharmaceuticals worth $401 as of Q2 2026.
BioMarin Pharmaceuticals was a new Planning Strategies Inc. position in Q2 2026.
BioMarin Pharmaceuticals made up ﹤0.01% of Planning Strategies Inc.'s portfolio in Q2 2026, its #896 holding.
142 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Planning Strategies Inc.'s 13F filing for Q2 2026, filed 27 Jul 2026.